信義香港(08328.HK)一季度實現收益2960萬港元 減幅26.8%
格隆匯5月15日丨信義香港(08328.HK)發佈公告,截至2020年3月31日止三個月,實現收益2960萬港元,減幅為26.8%。收益減少主要由於2019冠狀病毒疫症爆發導致農曆新年假期後集團鋰電池產品的生產活動延遲復工,且集團延遲向客户交付產品。停工及延誤導致集團來自電池包及儲能系統以及叉車貿易的業務分部的收益鋭減50.2%。集團已於2020年2月下旬恢復生產活動,而董事認為集團的業務並無任何重大惡化。
報告期內,公司擁有人應占溢利為20萬港元(2019年:340萬港元)。盈利能力下降主要是由於上文所分析的集團營運表現所致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.